JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB201801

DyLight® 594 Conjugation Kit (Fast) - Lightning-Link®

Be the first to review this product! Submit a review

|

(7 Publications)

DyLight® 594 Conjugation Kit (Fast) - Lightning-Link® (ab201801) offers several standout features:

- Rapid Conjugation: achieve DyLight® 594 labeling in under 20 minutes with just 30 seconds of hands-on time.
- High Efficiency: ensures 100% antibody recovery, meaning no loss of valuable antibodies.
- Versatility: suitable for conjugating antibodies, proteins, and peptides. DyLight® 594 labeled antibodies can be used immediately in applications such as Western blot (WB), ELISA, and Immunohistochemistry (IHC) without further purification.
3 Images
Fluorescence Microscopy - DyLight® 594 Conjugation Kit (Fast) - Lightning-Link® (AB201801)
  • Fluorescence Microscopy

PubMed

Lalo, Ulyana, et al used DyLight® 594 Conjugation Kit (Fast) - Lightning-Link® (ab201801) as part of examining the colocalization of vesicular ATP transporters with exocytotic organelle markers. They used the kit to conjugate DyLight® 594 to various antibodies for use in multiphoton fluorescent microscopy.
Living, acutely isolated cortical astrocytes were labeled with antibodies to vesicular transporters (VNUT1 and VGLUT1) and synaptic vesicle (SV2A) and lysosomal (LAMP3 and Cathepsin-D) markers. Antibodies were conjugated to fluorescent dyes DyLight488 (green) and DyLight594 (red) prior to astrocyte labeling. (A-D) The representative two-photon fluorescence images (maximal intensity projections of Z-stack) and results of colocalization analysis, carried out using NIH ImageJ 1.43 software. The correlation between green and red fluorescence (images in the right column) is depicted as a product of the relative differences from the mean (PDM) for each pixel; the pseudocolor PDM images were generated as an output of ImageJ analysis routine. Positive values (bright yellow) are indicative for good co-localization of green and red signals, negative values (blue-violet) indicate segregation, and black color shows the lack of correlation. Note the different extent of scale for PDM values in (A-D). All scale bars in (A-D) are 5 μm.

Image from Lalo, Ulyana, et al., PLoS Biol., 12(1): e1001747; doi: 10.1371/journal.pbio.1001747. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Schematic Diagram - DyLight® 594 Conjugation Kit (Fast) - Lightning-Link® (AB201801)
  • Schematic Diagram

Supplier Data

This illustration demonstrates a general procedure of how the Lightning-Link®(Fast) labeling technology enables the direct labeling of antibodies or proteins.

Simply pipette your antibody or biomolecule of choice into the vial of a lyophilized mixture containing the label of interest and incubate for just 15 minutes. Please see the ab201801 protocol booklet for more details.

Learn more about our Lightning-Link® conjugation kits here

Flow Cytometry - DyLight® 594 Conjugation Kit (Fast) - Lightning-Link® (AB201801)
  • Flow Cyt

PubMed

Hsiao, Feng, et al used DyLight® 594 Conjugation Kit (Fast) - Lightning-Link® (ab201801) as part of examining SAMHD1 expression in tissue Tm subsets. They used the kit to conjugate DyLight® 594 to anti-SAMHD1 antibody for use in flow cytometry.
A) Validation of SAMHD1 antibody by flow cytometry. Unstimulated PBMCs were mock-treated or exposed for 3 days to F4.HSA. Depicted within the gates are the proportions of infected cells amongst the SAMHD1- and SAMHD1+ cells. The results demonstrate that SAMHD1- cells, which are permissive, harbor a higher proportion of infected cells than non-permissive, SAMHD1+ cells, as expected [3]. Results are pre-gated on live, singlet CD3+CD8-CD45RO+CD45RA- cells. B) Bar graph of the percentage of SAMHD1+ cells across the three indicated memory CD4+ T cell subsets from HLACs as determined by flow cytometry. Results are pre-gated on live, singlet CD3+CD8-CD45RO+CD45RA- cells. ns : non-significant as determined using a 2-tailed paired parametric t-test.

Image from Hsiao, Feng, et al., PLoS pathog., 16(4): e1008450; doi: 10.1371/journal.ppat.1008450. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Key facts

Product details

DyLight® 594 Conjugation Kit (Fast) - Lightning-Link® (ab201801) uses a simple and quick process for labeling / conjugation of antibodies. It can also be used to conjugate other proteins or peptides.

To conjugate an antibody to DyLight® 594 using this kit:
- add modifier to antibody and incubate for 15 min
- add quencher and incubate for 5 min

The DyLight® 594 conjugated antibody can be used immediately in Flow cytometry, WB, ELISA, IHC etc. No further purification is required and 100% of the antibody is recovered for use.

Learn about our antibody labeling kits and their advantages here.

Learn about buffer compatibility below; for incompatible buffers and low antibody concentrations, use our antibody purification and concentration kits.
Custom size conjugation kits up to 100 mg are available on demand. Please contact us to discuss your requirements.

Amount and volume of antibody for conjugation to Dylight® 594

Kit size Recommended
amount of antibody1
Maximum
amount of antibody
Maximum antibody
volume2
3 x 10 µg 3 x 10 µg 3 x 20 µg 3 x 10 µL
100 µg 1 x 100 µg 1 x 200 µg 1 x 100 µL
3 x 100 µg 3 x 100 µg 3 x 200 µg 3 x 100 µL
1 mg 1 x 1 mg 1 x 2 mg 1 x 1 mL

1 Using the maximum amount of antibody may result in less labelling per antibody.

2 Ideal antibody concentration is 1mg/ml. 0.5 - 1 mg/mL can be used if the maximum antibody volume is not exceeded. Antibodies > 2 mg/mL or < 0.5 mg/mL should be diluted /concentrated.

Buffer Requirements for Conjugation

Buffer should be pH 6.5-8.5.

Compatible buffer constituents
If a concentration is shown, then the constituent should be no more than the concentration shown. If several constituents are close to the limit of acceptable concentration, then this can inhibit conjugation.

50mM / 0.6% Tris1 0.1% BSA2 50% glycerol
0.1% sodium azide PBS Potassium phosphate
Sodium chloride HEPES Sucrose
Sodium citrate EDTA Trehalose

1 Tris buffered saline is almost always ≤ 50 mM / 0.6%
2 BSA can also interfere with the use of the conjugated antibody in tissue staining.

Incompatible buffer constituents

Thiomerosal Proclin Glycine
Arginine Glutathione DTT

If a constituent of the buffer containing your antibody or protein is not listed above, please contact us.

Only purified antibodies are suitable for use, ie. where other proteins, peptides, or amino acids are not present: antibodies in ascites fluid, serum or hybridoma culture media are incompatible.

Storing and handling conjugation kits

Lyophilized Lightning-Link® components are hygroscopic.

Kits are intentionally shipped at ambient temperature with silica gel to avoid exposure to moisture. Upon receipt, store the kit frozen and protect from moisture. Before opening the outer container, allow the lyophilized components to reach room temperature to minimize condensation.

DyLight® is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

This product is manufactured by Expedeon, an Abcam company, and was previously called Lightning-Link® Rapid DyLight® 594 Labeling Kit. 324-0015 is the same as the 1 mg size. 324-0030 is the same as the 3 x 10 µg size. 324-0010 is the same as the 3 x 100 µg size. 324-0005 is the same as the 100 µg size.

What's included?

{ "values": { "3x10g": { "sellingSize": "3 x 10 µg", "publicAssetCode":"ab201801-3x10ug", "assetComponentDetails": [ { "size":"3 x 10 µg", "name":"Dylight® 594 Conjugation Mix", "number":"AB201801-CMP01" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201801-CMP03" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201801-CMP02" } ] }, "3x100g": { "sellingSize": "3 x 100 µg", "publicAssetCode":"ab201801-3x100ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201801-CMP02" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201801-CMP03" }, { "size":"3 x 100 µg", "name":"Dylight® 594 Conjugation Mix", "number":"AB201801-CMP01" } ] }, "1mg": { "sellingSize": "1 mg", "publicAssetCode":"ab201801-1mg", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201801-CMP03" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201801-CMP02" }, { "size":"1 x 1 mg", "name":"Dylight® 594 Conjugation Mix", "number":"AB201801-CMP01" } ] }, "100g": { "sellingSize": "100 µg", "publicAssetCode":"ab201801-100ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201801-CMP03", "productcode":"" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201801-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Dylight® 594 Conjugation Mix", "number":"AB201801-CMP01", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Ambient - Cannot Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

Target data

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 14:1228374 PubMed37809074

2023

ß1-adrenergic blockers preserve neuromuscular function by inhibiting the production of extracellular traps during systemic inflammation in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Camille H Bourcier,Pauline Michel-Flutot,Laila Emam,Lucille Adam,Adeline Gasser,Stéphane Vinit,Arnaud Mansart

iScience 26:106514 PubMed37091227

2023

Semi-supervised analysis of myeloid and T cell behavior in ovarian tumor slices reveals changes in cell motility after treatments.

Applications

Unspecified application

Species

Unspecified reactive species

Florian Laforêts,Panoraia Kotantaki,Beatrice Malacrida,Samar Elorbany,Ranjit Manchanda,Emmanuel Donnadieu,Frances Balkwill

PLoS pathogens 16:e1008450 PubMed32353080

2020

Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Hsiao,Julie Frouard,Andrea Gramatica,Guorui Xie,Sushama Telwatte,Guinevere Q Lee,Pavitra Roychoudhury,Roland Schwarzer,Xiaoyu Luo,Steven A Yukl,Sulggi Lee,Rebecca Hoh,Steven G Deeks,R Brad Jones,Marielle Cavrois,Warner C Greene,Nadia R Roan

Methods in molecular biology (Clifton, N.J.) 2041:209-221 PubMed31646491

2019

Fluorescent Labeling and Quantification of Vesicular ATP Release Using Live Cell Imaging.

Applications

Unspecified application

Species

Unspecified reactive species

Kirstan A Vessey,Tracy Ho,Andrew I Jobling,Anna Y Wang,Erica L Fletcher

The Journal of clinical investigation 129:3277-3292 PubMed31112527

2019

Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Deepak Kumar Kaushik,Anindita Bhattacharya,Reza Mirzaei,Khalil S Rawji,Younghee Ahn,Jong M Rho,V Wee Yong

Journal of immunology (Baltimore, Md. : 1950) 201:3804-3814 PubMed30413671

2018

Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Awadalkareem Adam,Marcia Woda,Sonia Kounlavouth,Alan L Rothman,Richard G Jarman,Josephine H Cox,Julie E Ledgerwood,Gregory D Gromowski,Jeffrey R Currier,Heather Friberg,Anuja Mathew

PLoS biology 12:e1001747 PubMed24409095

2014

Exocytosis of ATP from astrocytes modulates phasic and tonic inhibition in the neocortex.

Applications

Unspecified application

Species

Unspecified reactive species

Ulyana Lalo,Oleg Palygin,Seyed Rasooli-Nejad,Jemma Andrew,Philip G Haydon,Yuriy Pankratov
View all publications
websiteProtocolBooklet
en
websiteProtocolBooklet
zh

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com